UMN Technology Commercialization is collaborating with CTSI’s Office of Discovery and Translation (ODAT) to support the development of novel solutions designed to reduce health disparities.

Claros Technologies, a UMN advanced materials startup, grows functional nanoparticles within plastics, ceramics, or textiles.

The valve-making procedure, which could spare children born with heart defects the need to undergo repeated surgeries, is licensed to UMN startup Vascudyne.